Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brix Medical Science is a medical technology company specializing in the development of innovative enzymatic solutions for dental care. The company is best known for Brix 3000, a patented enzymatic gel designed for the non-traumatic removal of dental caries. This product utilizes papain as its active ingredient, encapsulated using proprietary EBE (Encapsulated Buffer Emulsion) technology to ensure stability and selective action on infected dentin. By eliminating the need for traditional drilling and anesthesia in many cases, Brix Medical Science provides a more comfortable experience for patients, particularly in pediatric and geriatric dentistry. The company's technology focuses on bio-cleansing, which preserves healthy tooth structure while effectively removing decayed tissue. Brix Medical Science operates globally, providing its bio-active dental materials to practitioners seeking minimally invasive treatment options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brix Medical Science.